Funds holding Sichuan Biokin Pharmaceutical Co Ltd
ISIN CNE100006FN4 · China
- Fund holders
- 23
- Of which ETFs
- 15 8 other funds
- Value held
- 33.5M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 220,886 | 8.8M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 215,069 | 8.6M $ | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Core MSCI Emerging Markets ETF iShares, Inc. | 162,780 | 6.3M $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Xtrackers Harvest CSI 300 China A-Shares ETF DBX ETF Trust | 42,065 | 1.6M $ | 0.09 % | as of Feb 27, 2026 ↗ |
| iShares Emerging Markets Equity Factor ETF iShares, Inc. | 40,836 | 1.6M $ | 0.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 36,840 | 1.5M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares MSCI China ETF iShares Trust | 30,629 | 1.2M $ | 0.02 % | as of Feb 28, 2026 ↗ |
| KraneShares SSE Star Market 50 Index ETF Krane Shares Trust | 25,437 | 1M $ | 1.26 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Emerging Markets ETF iShares, Inc. | 24,728 | 952.9K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Schwab Emerging Markets Equity ETF SCHWAB STRATEGIC TRUST | 18,623 | 718.2K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 12,480 | 499.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| JNL Emerging Markets Index Fund JNL Series Trust | 5,600 | 227K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders Emerging Markets Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 4,395 | 175.5K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 3,138 | 121K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Franklin FTSE China ETF Franklin Templeton ETF Trust | 1,543 | 62.1K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| International Strategic Equity Allocation Fund John Hancock Funds II | 1,203 | 46.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund FlexShares Trust | 851 | 34K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| iShares Global Equity Factor ETF iShares Trust | 600 | 24K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 280 | 10.8K $ | 0.02 % | as of Feb 27, 2026 ↗ |
| Goldman Sachs MarketBeta Emerging Markets Equity ETF Goldman Sachs ETF Trust | 164 | 6.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Franklin FTSE Asia ex Japan ETF Franklin Templeton ETF Trust | 100 | 4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Emerging Markets Equity ETF BNY Mellon ETF Trust | 65 | 2.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity SAI Emerging Markets Index Fund Fidelity Salem Street Trust | 47 | 1.9K $ | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| KraneShares SSE Star Market 50 Index ETF Krane Shares Trust | 1.26 % | as of Mar 31, 2026 ↗ |
| iShares Emerging Markets Equity Factor ETF iShares, Inc. | 0.09 % | as of Feb 28, 2026 ↗ |
| Xtrackers Harvest CSI 300 China A-Shares ETF DBX ETF Trust | 0.09 % | as of Feb 27, 2026 ↗ |
| Franklin FTSE China ETF Franklin Templeton ETF Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| JNL Emerging Markets Index Fund JNL Series Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| JPMorgan BetaBuilders Emerging Markets Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 0.02 % | as of Apr 30, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 0.02 % | as of Feb 27, 2026 ↗ |
| iShares MSCI China ETF iShares Trust | 0.02 % | as of Feb 28, 2026 ↗ |
| iShares Global Equity Factor ETF iShares Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund FlexShares Trust | 0.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 23 | -19 | 848,359 | -10.9 % |
| 2026Q1 | 42 | +4 | 951,909 | -4.7 % |
| 2025Q4 | 38 | +5 | 998,600 | +28.3 % |
| 2025Q3 | 33 | +18 | 778,519 | +75.2 % |
| 2025Q2 | 15 | +5 | 444,424 | +49.0 % |
| 2025Q1 | 10 | +3 | 298,286 | +14.1 % |
| 2024Q4 | 7 | +3 | 261,500 | +85.9 % |
| 2024Q3 | 4 | +2 | 140,667 | +27.8 % |
| 2024Q2 | 2 | 110,048 |
Cite this page
Titelia. "Funds holding Sichuan Biokin Pharmaceutical Co Ltd". https://titelia.com/en/stocks/sichuan-biokin-pharmaceutical-co-ltd-CNE100006FN4